Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StimaWELL North America is a private medical device company focused on electrical muscle stimulation systems for pain relief, recovery, and rehabilitation. The company markets the StimaWELL 120MTRS, an FDA-cleared Class II electrotherapy device for neck and back pain that combines transcutaneous electrical nerve stimulation, neuromuscular electrical stimulation, and heat therapy. Its positioning spans rehabilitation, pain management, athletic recovery, and fitness applications rather than drug development. The business appears to serve as the North American commercialization arm for German-manufactured StimaWELL products. It is led by Jason Frohlich and is based in Montreal, Quebec.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StimaWELL North America.